Prospective, Open, Non-interventional Study to Assess the Ability of an Electrical Impedance Tomograph (PlumoVista 500)
PV500ped
1 other identifier
observational
23
1 country
1
Brief Summary
This observational PMCF study will be conducted to generate and gather clinical data from the intended target population of pediatric patients. The intention for Post-Market Clinical Follow-up (PMCF) is to confirm the performance and safety of a device throughout the device's lifecycle. PulmoVista 500 is a lung function monitor for clinical use which continuously generates cross-sectional images of the lung function by applying the technique of electrical impedance tomography (EIT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2021
CompletedStudy Start
First participant enrolled
May 3, 2021
CompletedFirst Posted
Study publicly available on registry
May 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 28, 2021
CompletedMarch 29, 2022
March 1, 2022
3 months
April 30, 2021
March 28, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
assess the capability of PulmoVista 500 for continuous monitoring of ventilation
To assess the capability of PulmoVista 500 for continuous monitoring of ventilation, the cross-correlation function (CCF) between the global impedance waveform of EIT and global tidal volume waveforms of a ventilator across multiple respiratory cycles in patients under controlled mechanical ventilation, will be evaluated.
Duration per participant: 2 - 3 days (screening, procedure with PulmoVista 500, safety follow-up). Measurements with PulmoVista 500 per patient during mechanical ventilation is anticipated for a maximum of 10 minutes in total.
Eligibility Criteria
Pediatric patients that visit the hospital for any kind of surgery, therefore requireing mechanical ventilation. Monitoring of Regional Distribution of Ventilation and Lung Volume are of clinical interest in these patients.
You may qualify if:
- Pediatric male or female patients excluding preterm infants
- Patients with a chest circumference between 36 and 72 cm
- Patients ≤ 12 years.
- Patients with a tidal volume \> 20 ml, i.e., children with a body weight of more than 3.3 kg (assuming a targeted tidal volume of 6 mL/kg body weight)
- Patients for whom mechanical ventilation is intended
- Patients whose regional distribution of ventilation and of lung volume are of clinical interest
- Patients who are (should be) ventilated via an artificial airway access, whereby the ventilator used is compatible with PulmoVista 500
- Patients and / or their legal guardians or legal representatives who have given written informed consent to participate in the study
You may not qualify if:
- Patients who are supplied with a permanent or temporary pacemaker, an implantable defibrillator or other medical devices that emit electrical energy (e.g. cochlea amplifier implant)
- Patients with a tidal volume ≤ 20 ml
- Patients in whom the application of the electrode belt could be impaired by wound care or infections in the chest area
- Female patients for whom pregnancy cannot be excluded; a pregnancy test should be performed at the discretion of the investigator.
- Patients with an alleged allergic reaction to the materials of the electrode belt
- Patients with a Body Mass Index (BMI) \> 40
- Evidence that suggests that the patient or their legal representative will not comply with the protocol requirements
- Patients with a proven infectious disease (e.g. SARS-COV-19, MRSA) that requires isolation of the patient
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Klinik für Kinder- und Jugendmedizin Klinikum Traunstein
Traunstein, 83278, Germany
Related Publications (1)
Clasen D, Winter I, Rietzler S, Wolf GK. Changes in ventilation distribution during general anesthesia measured with EIT in mechanically ventilated small children. BMC Anesthesiol. 2023 Apr 12;23(1):118. doi: 10.1186/s12871-023-02079-z.
PMID: 37046213DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Gerhard Wolf, PD Dr.
Children's hospital Traunstein
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 30, 2021
First Posted
May 5, 2021
Study Start
May 3, 2021
Primary Completion
July 28, 2021
Study Completion
July 28, 2021
Last Updated
March 29, 2022
Record last verified: 2022-03